-

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of DexCom, Inc. (NASDAQ: DXCM) for potential breaches of fiduciary duties and violations of the federal securities laws.

What is Johnson Fistel Investigating? Between April 28, 2023 and June 5, 2024, certain DexCom insiders caused the company to issue false and misleading public statements regarding its expansion strategy and purported market share. However, beginning on April 25, 2024, DexCom made its first in a series of public corrective disclosures announcing that the company’s growth and business prospects were far lower than it had previously claimed. By the time the company made its final corrective disclosure on July 25, 2024, the price of DexCom’s shares had plummeted by over 40.6%.

Current stockholders who held their DexCom stock before April 28, 2023, are encouraged to contact Johnson Fistel to discuss their legal rights in this matter. You can click or copy and paste the following link to join this investigation: https://www.johnsonfistel.com/investigations/dexcom-inc-2

About Johnson Fistel, PLLP:

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Johnson Fistel, PLLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Industry:

Johnson Fistel, PLLP

NASDAQ:DXCM
Release Versions
English

Contacts

Johnson Fistel, PLLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, PLLP

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of DICK’S Sporting Goods, Inc. (DKS)

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of DICK’S Sporting Goods, Inc. (NYSE: DKS) against certain of its officers and directors for alleged breaches of fiduciary duty.What Should DICK’S Shareholders Do?If you have held DICK’S shares continuously since prior to May 25, 2022, you may have standing to seek corporate governance reforms at DICK’S, including improvements to internal controls, transparency, and exe...

CCB Investor Notice: Johnson Fistel Investigates Coastal Financial Corporation Following $68.8 Million Credit Expense

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating Coastal Financial Corporation (NASDAQ: CCB) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. If you purchased Coastal Financial securities and suffered losses, click here to join the investigation. Why Is Johnson Fistel Investigating Coastal Financial? On July 30, 2026, Coastal Financial reported a quarterly net loss of $42.1 million, primarily attributable to $...

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of REGENXBIO Inc. (RGNX)

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of REGENXBIO Inc. (NASDAQ: RGNX) against certain of its officers and directors for alleged breaches of fiduciary duty. Shareholders who have held REGENXBIO shares continuously since prior to February 9, 2022, may have standing to seek corporate governance reforms, the return of funds to the Company, and a court-approved incentive award, all at no cost to them. What Sho...
Back to Newsroom